Article
Selection of genotypes harbouring mutations in the cytochrome b gene of Theileria annulata is associated with resistance to buparvaquone.
PloS one - 1 Jan 2023
Hacılarlıoglu Selin, Bilgic Huseyin Bilgin, Bakırcı Serkan, Tait Andrew, Weir William, Shiels Brian, Karagenc Tulin
Abstract excerpt
Buparvaquone remains the only effective therapeutic agent for the treatment of tropical theileriosis caused by Theileria annulata. However, an increase in the rate of buparvaquone treatment failures has been observed in recent years, raising the possibility that resistance to this drug is associated with the selection of T. annulata genotypes bearing mutation(s) in the cytochrome b gene (Cyto b). The aim of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
